Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DrNancyM_CDC: I’m a vaccine expert, a disease detective and a mom. I say #ivax2protect when it comes to my children. #HCPs, shar… https://t.co/tZ0dd5RTS6
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA’s actions on youth e-cigarette use include retailer blitz to crack down on illegal sale of JUUL to minors. We’re also requiring JUUL Labs to submit important documents to better understand reportedly high rates of youth use/appeal of these products:
SteveFDA (R-D.C.)
@SGottliebFDA
RT @annaedney: FDA cracks down on Juul e-cigarettes, something teens have been super into, and retailers that sell them to kids https://t.co/Auw7hWtbRK
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is taking new steps today - as part of a broader, ongoing campaign - to stop youth use of e-cigarettes. No child should use any tobacco product. Today’s actions are part of a campaign that’ll include additional enforcement actions in the coming weeks
SteveFDA (R-D.C.)
@SGottliebFDA
Today #FDA is announcing several new actions and efforts to stop youth use of, and access to, JUUL and other e-cigarettes. We must – and will – move quickly to address the surging youth uptake of JUUL and other products: https://t.co/vlwBMXvLK1
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Today #FDA is announcing several new actions and efforts to stop youth use of, and access to, JUUL and other e-ciga… https://t.co/IhXRwNjLQb
SteveFDA (R-D.C.)
@SGottliebFDA
I hope these actions send a clear message to all tobacco product manufacturers/ retailers that the #FDA is taking on this issue w/ urgency, and if kids are flocking to your product or you’re illegally selling these products to kids, you’re on FDA’s radar:
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA’s overarching goal – one we hope everyone shares – is to make sure JUUL and any other tobacco products aren’t getting into kids’ hands in the first place. Today’s actions are the first in a series of efforts we’re pursuing. We’ll have more to say in
SteveFDA (R-D.C.)
@SGottliebFDA
Since early March, #FDA has issued 40 warning letters to retailers for illegal sales of JUUL products to minors as a result of the blitz and sustained enforcement efforts to reduce tobacco product sales to youth. Additional warning letters are expected: h
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: “As we’ve said before, there is no acceptable number of children using tobacco products. We share the belief that t… https://t.co/CcpCHWqXEv
SteveFDA (R-D.C.)
@SGottliebFDA
RT @lauriemcginley2: FDA cracks down on sales of Juul to youth. It looks like a USB flash drive and comes in flavors like mango. My story https://t.co/XbYKZZRiDZ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: Remarks from @SGottliebFDA as prepared for testimony before a U.S. Senate Committee on Appropriations on FDA’s Fisc… https://t.co/zwY6nMSqpt
SteveFDA (R-D.C.)
@SGottliebFDA
The #FDA is requesting, as part of the President’s budget, resources to modernize generic drug development to enable increased competition and lower drug costs to provide more affordable drug options for patients. https://t.co/a2bbSGdZKa
SteveFDA (R-D.C.)
@SGottliebFDA
Generic drugs that reference discontinued or withdrawn brand drugs comprise about 1/5 of the total number of reference-listed drugs. #FDA can play more active role to help bring these drug labels up to date, promote more widespread use of generics. https:
SteveFDA (R-D.C.)
@SGottliebFDA
Join #FDA on July 9 for a Patient-Focused Drug Development meeting for Chronic Pain. FDA wants patients’ views on chronic pain, treatments, and challenges to accessing treatments. #PFDD Learn more: https://t.co/Zf9kfDWBWs https://t.co/FTDKdVjHes
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA FY 2019 Budget includes $100 million to advance the use of real-world experience to inform patient care and provide efficient and potentially lower cost ways to develop clinical data to expedite medical product development. https://t.co/a2bbSGdZKa
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA must also support development of surveillance systems that will enhance our understanding of medical product safety and efficacy in real time. Includes broadening our use of data from electronic health records, among other sources. https://t.co/a2bbS
SteveFDA (R-D.C.)
@SGottliebFDA
RT @LizSzabo: F.D.A. Cracks Down on Sales of E-Cigarettes to Minors https://t.co/8IvfdfEfb7
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: America’s youth should not be using tobacco products. We at #HHS are proud of the work @SGottliebFDA & @US_FDA are doing to cr… QT @SGottliebFDA: Today #FDA is announcing several new actions and efforts to stop youth use of, and access to, JUUL and other e-ciga… https://t.co/IhXRwNjLQb)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAWomen: Your input is crucial: FDA’s seeks your comments through June 14 on lowering nicotine in cigarettes via @FDATobacco… https://t.co/MGxQ3KOstY